Vaiman, E.E.,
Shnayder, N.A.,
Zhuravlev, N.M.,
Petrova, M.M.,
Asadullin, A.R.,
Al-Zamil, M.,
Garganeeva, N.R.,
Shipulin, G.A.,
Cumming, G.,
Nasyrova, R.F. (2022) , and monotherapy, etc.) and non-modifying factors (
genetic predisposition, gender,
age, etc.). The
geneticThe role of
genetic factors in levodopa-induced dyskinesias development in Russian patients
Sharipov, R.A.,
Omarov, M.A.,
Mulyukov, A.R.,
Dybova, A.I.,
Vyaseleva, E.T.,
Kayumova, N.B.,
Saitgalina, A. Sh.,
Ententeev, K.R.,
Iagafarov, I.R.,
Kuserbaev, I.V.,
Gubaeva, E.A. (2023) and
genetics. However, the application of the CRISPR/Cas9 technology has some limitations and difficulties
ASSOCIATIONS OF THE NRF2/KEAP1 PATHWAY AND ANTIOXIDANT DEFENSE GENE POLYMORPHISMS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASEKorytina, G.F.,
Akhmadishina, L.Z.,
Aznabaeva, Y.G.,
Kochetova, O.V.,
Zagidullin, N.S.,
Kzhyshkowska, J.G.,
Zagidullin, S.Z.,
Viktorova, T.V. (2019) /KEAP1 signaling system, and antioxidant defense gene
polymorphisms with COPD in population from Russia